Cough, Cold and Allergy (Hay Fever) Remedies in Macedonia
- Published: May 2012
Cough, cold and allergy (hay fever) remedies increased by a healthy 4% in current value terms in 2012, reaching €75 million. The category saw several switches take place in previous years, which increased self-medication and boosted OTC sales. Moreover, allergy levels in Finland are increasing, and cold winters also tend to give a boost to sales. The winter at the beginning of 2012 was also very cold, increasing demand for cough, cold and allergy (hay fever) remedies.
Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Finland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.
Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution
READ MORE >
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN FINLAND
Euromonitor International
April 2013
LIST OF CONTENTS AND TABLES
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2007-2012
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2007-2012
Table 3 Sales of Decongestants by Category: Value 2007-2012
Table 4 Sales of Decongestants by Category: % Value Growth 2007-2012
Table 5 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2008-2012
Table 6 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2009-2012
Table 7 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2012-2017
Table 8 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2012-2017
Leiras Finland Oy Ab in Consumer Health (finland)
Strategic Direction
Key Facts
Summary 1 Leiras Finland Oy Ab: Key Facts
Summary 2 Leiras Finland Oy Ab: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 3 Leiras Finland Oy Ab: Competitive Position 2012
Orion Oyj in Consumer Health (finland)
Strategic Direction
Key Facts
Summary 4 Orion Oyj: Key Facts
Summary 5 Orion Oyj: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 6 Orion Oyj: Competitive Position 2012
Valioravinto Oy Ab in Consumer Health (finland)
Strategic Direction
Key Facts
Summary 7 Valioravinto Oy Ab: Key Facts
Summary 8 Valioravinto Oy Ab: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 9 Valioravinto Oy Ab: Competitive Position 2012
Vitabalans Oy in Consumer Health (finland)
Strategic Direction
Key Facts
Summary 10 Vitabalans Oy: Key Facts
Summary 11 Vitabalans Oy: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 12 Vitabalans Oy Ab: Competitive Position 2012
Executive Summary
Economic Downturn Challenges Growth
Demand for Trendy Products
Tightening Competition
Internet Chemists/pharmacies See An Increase in Sales
Modest, Albeit Steady Growth Is Expected
Key Trends and Developments
Finnish Economy Under Threat
Demographic Changes To Be Considered
Vitamins and Dietary Supplements Faces Strong Competition and Negative Publicity
Obesity and Excess Weight Drive Sales
Internet Chemists/pharmacies Are Liberalised
Market Indicators
Table 9 Consumer Expenditure on Health Goods and Medical Services 2007-2012
Table 10 Life Expectancy at Birth 2007-2012
Market Data
Table 11 Sales of Consumer Health by Category: Value 2007-2012
Table 12 Sales of Consumer Health by Category: % Value Growth 2007-2012
Table 13 Consumer Health Company Shares 2008-2012
Table 14 Consumer Health Brand Shares 2009-2012
Table 15 Penetration of Private Label by Category 2007-2012
Table 16 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
Table 17 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
Table 18 Forecast Sales of Consumer Health by Category: Value 2012-2017
Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 13 OTC-Switches 2009-2012
Sources
Summary 14 Research Sources
CH06ccFI
Companies Mentioned Include:
- Orion Group
- Pfizer Oy
- Leiras Oy
- Ferrosan Ab Oy
- Procter & Gamble Finland Oy
- SmithKline Beecham Oy
- Novartis Finland Oy
- Roche Oy
- GlaxoSmithKline Oy
- Pharmakon Oy
- UCB Pharma Finland Oy
- Sankyo Pharma Finland AB Oy
- Johnson & Johnson Inc
- Alpharma Oy
- Cederroth Oy
- Ratiopharm Oy
- Warner-Lambert Co LLC
- Lysi Ltd
- Madaus AG
- AstraZeneca Oy
- Beiersdorf Oy
- Bayer AG
- Vitabalans Oy
- Cloetta Fazer AB
- Santen Oy
- Janssen-Cilag Oy
- Solvay SA
- Leaf Oy
- Laboratory Lyocentre
- Sanofi Winthrop International
- Ortis, Laboratoires
- Suomen Bioteekki Oy
- Lofthouse of Fleetwood Ltd
- Nycomed AB Oy
- Schering-Plough Oy
- Reckitt Benckiser Plc
- Ferring AS
- Whitehall Laboratories
- Boehringer Ingelheim KG
- Larste Oy
- Boots Co Plc, The
- Haw Par Healthcare Ltd
- Ciba Vision Finland Oy
- Allergan Ltd
- A Vogel Oy
- Yamanouchi Pharmaceutical Co Ltd
- Bioforce AG
- Suomen Rohdos Oy
- Suomen 3M Oy
- Aventis Pharma Oy
- Alcon Finland Oy
- Scholl Plc
- Fenno Natura Oy AB
- CCV Vertriebs GmbH
- Merck Oy
- Lövens Oy
- Kent Gida Maddeleri Sanayii ve
- Ticaret AS
| Format | Properties | |
|---|---|---|
| Electronic (PDF) | The report will be emailed to you. The report is sent in PDF format. | This is a single user license, allowing one specific user access to the product. |
| Site License | The report will be emailed to you. The report is sent in PDF format. | This is a site license, allowing all users within a given geographical location of your organisation access to the product. |
| Enterprisewide | The report will be emailed to you. The report is sent in PDF format. | This is an enterprise license, allowing all employees within your organisation access to the product. |